Clinical Performance of Splinted 4.5-mm Extra-Short Implants: A Controlled Retrospective Cohort Study

Abstract

This study compared the survival, marginal bone loss (MBL), and prosthetic complications of 4.5-mm extra-short implants and longer implants splinted to the short implants via the restoration. A retrospective controlled cohort study was performed. The 4.5-mm extra-short group (study group; SG) included 48 consecutively placed implants. The control group (CG) included 48 implants splinted to the extra-short implants. The same surgical team treated the 39 included patients, and all implants were restored with a screw-retained fixed restoration and intermediate abutments. Im- mediate and conventionally loaded implants were included. All implants were in function during the follow-up period (14 ± 3.4 and 17 ± 13 months for SG and CG, respectively). No differences in techni- cal complications were observed between the groups (one and two cases of screw loosening for SG and CG, respectively; two provisional prosthesis fractures for SG; P = .310). Marginal bone stability was similar for SG and CG at the mesial level (-0.01 ± 0.28 mm for SG vs -0.18 ± 0.72 mm for CG; P = .270) and at the distal level (0.02 ± 0.39 mm for SG vs -0.18 ± 0.68 mm for CG; P = .076). The same good clinical performance could be observed for 4.5-mm implants and longer implants under the same prosthesis. Keywords: extra-short implants; marginal bone stability; short dental implants.

— actualidad · noticias ›

BTI Biotechnology Institute supera una década de liderazgo científico entre las bioempresas españolas

miércoles, 10 de junio de 2026

BTI Biotechnology Institute vuelve a situarse como la empresa biotecnológica española con mayor producción científica, con un total de 29 publicaciones recogidas en el Informe AseBio 2025.

Int J Periodontics Restorative Dent

2,024

Autores:
Asier Eguía, Eduardo Anitua Aldecoa, Mohammad H. Alkhraisat

Abstract

This study compared the survival, marginal bone loss (MBL), and prosthetic complications of 4.5-mm extra-short implants and longer implants splinted to the short implants via the restoration. A retrospective controlled cohort study was performed. The 4.5-mm extra-short group (study group; SG) included 48 consecutively placed implants. The control group (CG) included 48 implants splinted to the extra-short implants. The same surgical team treated the 39 included patients, and all implants were restored with a screw-retained fixed restoration and intermediate abutments. Im- mediate and conventionally loaded implants were included. All implants were in function during the follow-up period (14 ± 3.4 and 17 ± 13 months for SG and CG, respectively). No differences in techni- cal complications were observed between the groups (one and two cases of screw loosening for SG and CG, respectively; two provisional prosthesis fractures for SG; P = .310). Marginal bone stability was similar for SG and CG at the mesial level (-0.01 ± 0.28 mm for SG vs -0.18 ± 0.72 mm for CG; P = .270) and at the distal level (0.02 ± 0.39 mm for SG vs -0.18 ± 0.68 mm for CG; P = .076). The same good clinical performance could be observed for 4.5-mm implants and longer implants under the same prosthesis. Keywords: extra-short implants; marginal bone stability; short dental implants.

Artículos relacionados

Continúa tu investigación a través de nuestra selección de publicaciones vinculadas. Descubre estudios complementarios que abordan áreas temáticas, enfoques clínicos o desarrollos afines, diseñados para enriquecer tu comprensión sobre este campo científico.

LESIONES NERVIOSAS

The Effectiveness of Plasma Rich in Growth Factors in the Treatment of Nerve Compression Syndromes of the Upper Extremity

Galan V, Inigo-Dendariarena I, Galan J, Prado R, Padilla S, Anitua E. J Clin Med. 2022 Aug 16;11(16):4789.

LESIONES NERVIOSAS

The Effectiveness of Plasma Rich in Growth Factors in the Treatment of Nerve Compression Syndromes of the Upper Extremity

Galan V, Inigo-Dendariarena I, Galan J, Prado R, Padilla S, Anitua E. J Clin Med. 2022 Aug 16;11(16):4789.

LESIONES NERVIOSAS

The Effectiveness of Plasma Rich in Growth Factors in the Treatment of Nerve Compression Syndromes of the Upper Extremity

Galan V, Inigo-Dendariarena I, Galan J, Prado R, Padilla S, Anitua E. J Clin Med. 2022 Aug 16;11(16):4789.

Contacta

Close-up
Nombre *

Apellidos *

Correo electrónico *

¿Cómo quieres que contactemos contigo? *

Teléfono *

Código postal *

País *

Escribe aquí tu consulta *